Next Article in Journal
Homoisoflavanones from Agave tequilana Weber
Next Article in Special Issue
Design, Synthesis and Structure-activity Studies of Rhodanine Derivatives as HIV-1 Integrase Inhibitors
Previous Article in Journal
A Facile One-Pot Synthesis of α-Bromo-α,β-unsaturated Esters from Alcohols
Previous Article in Special Issue
Novel Indole-Based Analogs of Melatonin: Synthesis and in Vitro Antioxidant Activity Studies
Article Menu

Export Article

Open AccessReview
Molecules 2010, 15(5), 3281-3294;

4D-QSAR: Perspectives in Drug Design

Laboratory of Molecular Modeling, Faculty of Pharmacy, Federal University of Goiás, 1ª Av. c/ Praça Universitária, S/N., Goiânia, Goiás, 74605-220, Brazil
College of Pharmacy, MSC09 5360, 1 University of New Mexico, Albuquerque, New Mexico 87131-0001, USA
Faculty of Pharmaceutical Sciences, Av. Prof. Lineu Prestes, 580, University of Sao Paulo, Sao Paulo, 05508-900, Brazil
The Chem21 Group, Inc., 17870 Wilson Drive. Lake Forest, IL 60045, USA
Author to whom correspondence should be addressed.
Received: 1 March 2010 / Revised: 30 March 2010 / Accepted: 6 April 2010 / Published: 4 May 2010
(This article belongs to the Special Issue Structure-Based Drug Design)
Full-Text   |   PDF [2711 KB, uploaded 18 June 2014]   |  


Drug design is a process driven by innovation and technological breakthroughs involving a combination of advanced experimental and computational methods. A broad variety of medicinal chemistry approaches can be used for the identification of hits, generation of leads, as well as to accelerate the optimization of leads into drug candidates. The quantitative structure–activity relationship (QSAR) formalisms are among the most important strategies that can be applied for the successful design new molecules. This review provides a comprehensive review on the evolution and current status of 4D-QSAR, highlighting present challenges and new opportunities in drug design. View Full-Text
Keywords: QSAR; 4D-QSAR; Structure-based QSAR; Drug Design QSAR; 4D-QSAR; Structure-based QSAR; Drug Design

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Andrade, C.H.; Pasqualoto, K.F.M.; Ferreira, E.I.; Hopfinger, A.J. 4D-QSAR: Perspectives in Drug Design. Molecules 2010, 15, 3281-3294.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top